Novostia attended the EACTS (European Association of Cardio-Thoracic Surgery) Congress held in Milan this October 2022. During this event, one of our key partners for preclinical in vivo studies, the University of Leuven represented by Professors Bart Meuris and Tom Langenaeken, presented the latest results of animal studies with the TRIFLO valve. In the sidelines of this congress, Novostia convened its pool of Medical Advisors, a team of eight internationally renowned surgeons, all very active in the quest for premium cardiac valves and fervent supporters of the TRIFLO, to pave the way for the FIHs that will start in a dozen months.
